ETFdb Logo
  • ETF Database
  • Content Hubs
    • Themes
      • Active ETF
      • Alternatives
      • Artificial Intelligence
      • China Insights
      • Core Strategies
      • Crypto
      • Disruptive Technology
      • Energy Infrastructure
      • ETF Building Blocks
      • ETF Investing
      • ETF Strategist
      • Financial Literacy
      • Fixed Income
      • Free Cash Flow
      • Future ETFs
      • Innovative ETFs
      • Institutional Income Strategies
      • Leveraged & Inverse
      • Market Insights
      • Market Outlooks
      • Modern Alpha
      • Nuclear Energy
      • Portfolio Strategies
      • Sector Investing
      • Tax Efficient Income
      • Thematic Investing
    • Asset Class
      • Equity
        • U.S. Equity
        • Int'l Developed
        • Emerging Market Equities
      • Alternatives
        • Gold/Silver/Critical Materials
        • Cryptocurrency
        • Currency
        • Volatility
      • Fixed Income
        • Investment Grade Corporates
        • US Treasuries & TIPS
        • High Yield Corporates
        • Int'l Fixed Income
    • ETF Ecosystem
    • ETFs in Canada
    • Market Outlook
    • Crypto ETF Hub
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Database Categories
    • Indexes
    • Scenario Analysis
    • Watchlists
    • Head-To-Head ETF Comparison Tool
    • Mutual Fund To ETF Converter
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Sectors
    • Sector Investing Content Hub
    • XLK
    • XLI
    • XLU
    • XLY
    • XLP
    • XLRE
    • Sector Power Rankings
    • XLE
    • XLC
    • XLF
    • XLV
    • XLB
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • Gaining Perspective Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Free sign up
    • Login
  1. Core Strategies Content Hub
  2. 3 Stocks to Watch in Active Growth ETF FDG
Core Strategies Content Hub
Share

3 Stocks to Watch in Active Growth ETF FDG

Nick Peters-GoldenJun 04, 2024
2024-06-04

What better way to get a sense of an ETF than to understand its stocks? One key challenge for investors right now — avoiding overconcentration risk from the big, big tech names — merits looking for strategies outside that space.

An active growth ETF that looks for firms that meet growth of fundamental metrics outside that top list could provide a strong option. In this case, the American Century Focused Dynamic Growth ETF (FDG C+)could appeal, with three stocks outside of the big mega-cap techs.

See more: As Advisors Underweight Large Cap Growth, Try FDG

FDG charges 45 basis points for its exposures. The strategy invests in large- and midcap names with potential for high growth and profits. It crafts a portfolio of 30 to 45 firms best-suited for long-term capital appreciation. It looks to outperform the benchmark through strong stock identification. So what kind of stocks can be found in the active growth ETF?

Intuitive Surgical (ISRG)

Intuitive Surgical works on robotics in medicine and surgery, particularly. The stock has returned 48.4% for investors over the last three years, according to YCharts. That compares well to just 32% in returns for the S&P 500 Total Return Index (SPXTR). Though it has a high P/E ratio, it continues to offer appealing earnings-per-share (EPS), with a 51% quarterly year-over-year (YoY) growth rate for its diluted EPS.

HubSpot, Inc. (HUBS)

HubSpot, Inc. has shown its performance over a longer time frame than ISRG has. It has returned much more than ISRG as an investment over five years, per YCharts. HUBS has returned 268.1% over five years. The company provides cloud-based marketing, sales, and customer service on its software platform. It has seen 23.1% quarterly YoY revenue growth, per YCharts.

Regeneron Pharmaceuticals (REGN)

REGN works on products that fight eye and cardiovascular diseases as well as cancer, per YCharts. The firm’s P/E ratio appeals quite a bit, at about 22.6. It has returned 225.5% over the last five years, which also outperformed the SPXTR in that time.

Together, those stocks represent some intriguing finds by the active growth ETF, which has returned 33.6% over the last one-year period. For those investors looking for a solid long-term hold in an active growth format, FDG may appeal.

For more news, information, and analysis, visit the Core Strategies Channel.


Content continues below advertisement

Loading Articles...

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X